Hints and tips:
Related Special Reports
...Mr Hargreaves sold his stake just days after Michael Howard, the founder of rival investment platform IntegraFin disposed of a £39.5m stake — in part for “diversification purposes”....
...Continuing to boost top-line growth when patents are expiring on key drugs is “very difficult to achieve . . . but it will not stop companies from trying”, notes John Rountree, a partner in Novasecta, a...
...Electronics Joint Winners: Future; KAZ Minerals Award sponsor: Design Portfolio CEO of the Year Award Shortlist: Geoff Drabble/Ashtead Group; Ian Page/Dechra Pharmaceuticals; Duncan Painter/Ascential; Kevin Rountree...
International Edition